Interview with Angela Trismitro , President Director, Dos Ni Roha
Which are the main transformations Dos Ni Roha has undergone in recent years? Dos Ni Roha has successfully taken advantage of its wide expertise in the Indonesian market ? based…
PT Darya-Varia Laboratoria Tbk (“Darya-Varia” or “the Company”) is a long-established pharmaceutical company in Indonesia that first commenced its operations in 1976. In line with its mission to “build a healthier Indonesia one person at a time”, Darya-Varia produces high quality products for both Consumer Health and Ethical product lines, building strong, respected brands that are recognized throughout Indonesia. By following a consistent and relationship-driven engagement approach, the Company is moving to achieve its vision to be a top-five pharmaceutical company in Indonesia.
Contact
Address: South Quarter, Tower C, 18th -19th Floor
Jl. R.A. Kartini, Kav.8. Jakarta 12430, Indonesia
Tel: +62 21 227 68000
Website: http://www.darya-varia.com
Which are the main transformations Dos Ni Roha has undergone in recent years? Dos Ni Roha has successfully taken advantage of its wide expertise in the Indonesian market ? based…
APL is part of Zuellig, the top Asian pharmaceutical distributor. How does being part of a large, regionally specialized player help APL here in Indonesia? Being a part of Zuellig…
Many multinational companies have chosen to forgo establishing production facilities in Indonesia or have even shuttered their facilities, as did Janssen-Cilag. With the recent 10/10 decree, it seems the environment…
The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect…
How has the increasing international integration of the Indonesian economy influenced the challenges and transformations the BPOM went through in the past 9 years since its reorganization? The constant changes…
Millennium Pharmacon International has a long history, starting at its founding in 1952. Could you give our readers an overview of the company’s milestones, particularly those from the past decade?…
While the level of sales for pharmaceutical products is plunging in the US and Europe one of the core pillar of Solvay’s strategy is to have a stronger focus on…
The Indonesian Pharmaceutical industry has always held tremendous potential. Yet, somehow, over the past decades, the local industry was quickly dwarfed by regional powerhouses India and China, and even surpassed…
Since the installation of Mr. Fred Hassan in 2003, Schering-Plough has been oriented toward changes. At two years from your arrival you have been able to achieve IDR 170 billion…
See our Cookie Privacy Policy Here
